Tag: Anaplastic lymphoma kinase

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Anaplastic lymphoma kinase

ArriVent's Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window

Added to Collection on: 2024-01-26 16:48:04

Tags for this article:

Tyrosine kinase receptors
Epidermal growth factor receptor
Non-small-cell lung cancer
RET proto-oncogene
Amivantamab
Protein kinase inhibitor
Anaplastic lymphoma kinase
Lung cancer
ArriVent BioPharma

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details
Refining Adjuvant Immunotherapy Use is a Crucial Focus in Early-Stage NSCLC - OncLive

Added to Collection on: 2024-08-03 07:17:00

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Cancer treatments
Tyrosine kinase receptors
Adjuvant therapy
Non-small-cell lung cancer
Alectinib
Pembrolizumab
Nivolumab
Anaplastic lymphoma kinase
Epidermal growth factor receptor

Click the tags to see associated articles and topics

View Article Details
Lorlatinib vs Crizotinib in Advanced ALK-Positive NSCLC: 5-Year Outcomes From Phase III ...

Added to Collection on: 2024-08-08 15:58:08

Tags for this article:

Fluoroarenes
Pyrazoles
Lung cancer
Tyrosine kinase receptors
CYP3A4 inhibitors
Lorlatinib
Crizotinib
Brain metastasis
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Survival rate
Protein kinase inhibitor
Benjamin J. Solomon

Click the tags to see associated articles and topics

View Article Details
Capmatinib in MET Exon 14–Mutated NSCLC - The ASCO Post

Added to Collection on: 2024-10-15 16:08:54

Tags for this article:

Antineoplastic drugs
Tyrosine kinase receptors
Orphan drugs
Lung cancer
Capmatinib
Tyrosine kinase inhibitors
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Epidermal growth factor receptor
Protein kinase inhibitor
Sunvozertinib
Aumolertinib

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the ... - Placera

Added to Collection on: 2024-11-20 14:39:25

Tags for this article:

Lung cancer
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Alectinib
Small-cell carcinoma
Cancer research
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with ... - PR Newswire

Added to Collection on: 2024-11-20 14:34:06

Tags for this article:

Lung cancer
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Alectinib
Small-cell carcinoma
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies ... - Star Local Media

Added to Collection on: 2024-11-20 15:37:02

Tags for this article:

Lung cancer
Tyrosine kinase receptors
Anaplastic lymphoma kinase
ALK
Gene therapy
ALK positive lung cancer
ALK inhibitor
Genprex Inc.

Click the tags to see associated articles and topics

View Article Details
Alaska Air price target raised to $90 from $70 at Morgan Stanley | Markets Insider

Added to Collection on: 2024-12-11 19:23:22

Tags for this article:

Stock market
ALK
Overweight
Alaska Airlines
Anaplastic lymphoma kinase
New York Stock Exchange
Alaska Air
U.S. Airlines

Click the tags to see associated articles and topics

View Article Details
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates

Added to Collection on: 2025-01-24 15:50:32

Tags for this article:

Orphan drugs
CYP3A4 inhibitors
Cystic fibrosis
Antineoplastic drugs
Durvalumab
Ivacaftor
Tezacaftor
Respiratory syncytial virus
ALK inhibitor
Non-small-cell lung cancer
Crizotinib
Anaplastic lymphoma kinase

Click the tags to see associated articles and topics

View Article Details